GVK extends biomarker database deal with US FDA

Related tags Contract research organization Food and drug administration

Indian contract research organisation (CRO) GVK Biosciences has granted the US FDA continued access to its biomarker database in an extension of the organisations’ existing agreement.

GVK’s database, known as GioBiom, contains information on biomarkers that are currently being examined in preclinical development or clinical trials at sites around the world.

Under the extended deal, specifics of which have not been disclosed, the US Food and Drug Administration (FDA) will use the information to further develop its guidance on biomarker qualification, a draft version of which was published last October​.

GVK has worked with the FDA since 2007 when it granted the agency’s genomics group access to its database of clinical biomarkers for use in the development of its voluntary genomics data submission (VGDS) programme.

In the four years since that deal GVK’s database has grown from a list of around 300 compounds to over 12,000 biomarkers across all stages of clinical and clinical development.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Webinars

Headlines